• 临床试验进展缓慢： 尽管AI技术在分子设计、靶点发现起到提升效率和优化设计作用，但药物研发仍 需经过湿实验及较长的临床周期验证，产品进展存在不确定性。 本期Banglink从创业邦独家企业数据库睿兽分析精选11家AI药物研发领域优秀企业，覆盖多组学数据整 合、蛋白质结构预测、分子模拟优化、自动化实验平台、成药性智能评估等多个技术领域。如对精选项 目感兴趣，欢迎扫码进行委托联系！ AI药物研发是以数据驱动、算法赋能为核心，通过机器学习、生成式AI等技术重塑药物发现、优化及 临床试验全流程的创新领域。随着全球医药产业对效率提升的迫切需求，AI正从辅助工具升级为核心 驱动力 —— 据BCG报告，AI设计的药物分子在Ⅰ期临床试验成功率达80%-90%，远超传统方法的 40%-65%；部分企业已将药物发现周期从5-6年压缩至2-3年，研发成本降低30%-50%。 政策与资本双重加持下，行业进入爆发期：各国纷纷将AI制药纳入战略规划，国内《卫生健康行业人工 智能应用场景参考指引》明确84种应用场景，资本加速布局，2024年全球AI制药融资超50亿美元，晶泰 科技、英矽智能等企业管线快速推进，多款AI设计药物进入Ⅱ/Ⅲ ...

Core Viewpoints - The short-term catalysts for the A-share market may diminish, while the upcoming April earnings season could enhance profit pricing power [1][5] - External demand may face downward pressure, but the fundamental landscape still supports long-term bonds [1][4] Equity Market - Zhongtai Securities focuses on small-cap technology stocks, suggesting that they may benefit from capital expenditures by leading firms and local investments, potentially releasing performance elasticity this year [3] - Guohai Securities believes that financial and technology sectors may benefit from index breakthroughs, with a strong recovery in policy, monetary, or fundamentals being necessary for sustained upward movement [4] - Huatai Bairui Fund anticipates an increase in profit pricing power as the market risk appetite recovers, with a focus on emerging growth assets and dividend cash flow sectors benefiting from declining interest rates [5] Macroeconomic and Fixed Income - Penghua Fund indicates that the domestic economy is in a weak recovery trend, with real estate still seeking a bottom and external trade policies potentially dragging down exports [17] - Boshi Fund asserts that the fundamental landscape supports long-term bonds, with slow recovery in real estate and potential downward pressure on external demand [18] - CICC suggests that long-term interest rates may experience narrow fluctuations due to recent liquidity easing and a stable economic environment [19] Asset Allocation - Guolian Minsheng Securities recommends a barbell strategy in a volatile market, focusing on sectors with reasonable valuations and strong fundamentals while avoiding high-risk speculative areas [21][22]